Nat Commun
Nat Commun. 2026 Oct 14;17(1).
Abstract
Spatially resolved transcriptomics (SRT) measures gene expression within tissues. Existing methods that summarize the activity of functionally related genes often ignore relationships between neighboring locations and offer limited statistical testing, gene-level interpretation, or scalability.…
Spatially resolved transcriptomics (SRT) measures gene expression within tissues. Existing methods that summarize the activity of functionally related genes often ignore relationships between neighboring locations and offer limited statistical testing, gene-level interpretation, or scalability.…
Blood
Blood. 2026 Nov 12;148(20):2528-2539.
Abstract
Clonal cytopenia of undetermined significance (CCUS) is defined by unexplained cytopenias with myeloid-associated somatic mutations not meeting the diagnostic criteria for myelodysplastic syndromes/neoplasms (MDS), yet it carries a highly risk-stratified probability of progression to myeloid…
Clonal cytopenia of undetermined significance (CCUS) is defined by unexplained cytopenias with myeloid-associated somatic mutations not meeting the diagnostic criteria for myelodysplastic syndromes/neoplasms (MDS), yet it carries a highly risk-stratified probability of progression to myeloid…
Blood
Blood. 2026 Nov 12;148(20):2497-2510.
Abstract
Germ line gain-of-function (GOF) mutations in the signal transducer and activator of transcription 1 (STAT1) gene cause a dominantly inherited inborn error of immunity (IEI) characterized by chronic mucocutaneous candidiasis, autoimmunity, severe opportunistic infections, and an increased risk of…
Germ line gain-of-function (GOF) mutations in the signal transducer and activator of transcription 1 (STAT1) gene cause a dominantly inherited inborn error of immunity (IEI) characterized by chronic mucocutaneous candidiasis, autoimmunity, severe opportunistic infections, and an increased risk of…
Leukemia
Leukemia. 2026 Nov 11.
Abstract
Acute myeloid leukemia (AML) is a heterogeneous and aggressive hematologic malignancy associated with poor survival despite recent therapeutic advances. To identify novel anti-leukemic agents, we performed a high-throughput viability screen of 10,000 small molecules across 56 genetically diverse…
Acute myeloid leukemia (AML) is a heterogeneous and aggressive hematologic malignancy associated with poor survival despite recent therapeutic advances. To identify novel anti-leukemic agents, we performed a high-throughput viability screen of 10,000 small molecules across 56 genetically diverse…
Haematologica
Haematologica. 2026 Nov 12.
アブストラクト未収載
Haematologica
Haematologica. 2026 Nov 12.
アブストラクト未収載
Haematologica
Haematologica. 2026 Nov 12.
アブストラクト未収載
Int J Hematol
Int J Hematol. 2026 Nov 11.
Abstract
GATA2 deficiency is an inherited bone marrow failure and immunodeficiency syndrome with diverse infectious, hematologic, and systemic manifestations. Although well characterized in Western populations, its clinical phenotype in Japan remains insufficiently defined. We conducted a nationwide…
GATA2 deficiency is an inherited bone marrow failure and immunodeficiency syndrome with diverse infectious, hematologic, and systemic manifestations. Although well characterized in Western populations, its clinical phenotype in Japan remains insufficiently defined. We conducted a nationwide…
Exp Hematol
Exp Hematol Oncol. 2026 Nov 11;15(1).
Abstract
Tumor protein 53 (TP53) mutations, long recognized as harbingers of poor prognosis, drive treatment failure in hematologic malignancies by erecting two mutually reinforcing defense systems. Immune evasion is effected through silencing of death-receptor signaling, crippled antigen presentation, and…
Tumor protein 53 (TP53) mutations, long recognized as harbingers of poor prognosis, drive treatment failure in hematologic malignancies by erecting two mutually reinforcing defense systems. Immune evasion is effected through silencing of death-receptor signaling, crippled antigen presentation, and…